Skip to main content
. 2017 Feb 23;7(4):141–157. doi: 10.1177/2045125316689030

Table 1.

Psychotic reactions associated with ayahuasca and DMT.

Reference Study design Sample/drug Main findings
Lima et al. [2002] * Case series/observational
1996–2000
Brazilian UDV members
AYA (oral)
Seven cases of psychotic disorders$
Gable [2007] * Case series/observational
5 years (?)
Brazilian UDV members
AYA (oral)
13–24 cases of psychotic disorders
Dos Santos and Strassman [2008] Case report 21-year-old Brazilian man
AYA (oral)
Two psychotic episodes separated by 1 year
Lima and Tófoli, [2011] * Case series/observational
1994–2007
Brazilian UDV members
AYA (oral)
29 cases of psychotic disorders
Umut et al. [2011] Case report 19-year-old North American man
DMT (smoked?)
Psychotic episode
Warren et al. [2013] Case report 24-year-old South Australian man
DMT (smoked)
Psychotic episode
Szmulewicz et al. [2015] Case report 30-year-old Argentinian man
AYA (oral)
Psychotic episode
Paterson et al. [2015] Case report 42-year-old North American (?) man
DMT (smoked)
Psychotic episode
Described in the present review Case report 40-year-old Spanish woman
AYA (oral)
Psychotic episode

AYA, ayahuasca; DMT, dimethyltryptamine; UDV, União do Vegetal.

Interrogation: not specified.

*

Included subjects from the same sample.

$

Two cases did not present relation with ayahuasca, three cases were relapses of previous psychotic episodes, in one case, ayahuasca was associated with other factors (no details were given), and only one case presented immediate temporal relation with ayahuasca and there were no psychotic antecedents.

Schizophrenia (n = 9), acute and transient psychotic disorders (n = 4), unspecified nonorganic (n = 2), severe depressive episode with psychotic symptoms (n = 4), substance-induced psychosis (n = 6), and bipolar affective disorder with psychotic manic episode (n = 4). In 10 cases there was no immediate temporal relation between ayahuasca intake and the psychotic episode, and 19 of the 29 cases (65.5%) presented some relation with ayahuasca: in four cases, there was an immediate temporal relation between ayahuasca intake and the psychotic episode, and subjects had no psychiatric history; in five cases, there was an immediate temporal relation between ayahuasca intake and the psychotic episode, but subjects had a psychiatric history with or without an active symptomatology; and in 10 cases there was no immediate temporal relation between ayahuasca intake and the psychotic episode, but ayahuasca may have contributed with others factors for the development of the case.